Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Robin who wrote (2612)	6/9/1998 11:33:00 PM
From: Clayleas	Read Replies (1) \| Respond to of 5736

Robin, I think you can find the answers to all of your questions with a little DD using the reference page posted by Janybird in several places on this thread. To help you out a bit, the following are some of the answers. 1. The TLC-Bili correlated 95% with blood serum measurements (FYI, this is a very high correlation and was the reason CCSI got the FDA approval) 2. Yes it is accurate enough to replace heel sticks. I do understand that it will not completely eliminate heel sticks as blood is still necessary to run a series of other tests. 3. The use of the device will go beyond initial assessment. It is also unique in that it can be used under photo-therapy conditions. 4. The unit will be calibrated with a proprietary disposable that will provide a stream of income to CCSI as the devices are used in the field. Hope this helps Jim